Everest Organics Ltd

NSE: EVERESTO · BSE: 524790 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹243.90
Market cap: ₹236.8 Cr
Revenue (annual): ₹196.2 Cr
Net profit (annual): ₹5.55 Cr
P/E (TTM): 45.1×Sector 47.4×
Promoter holding: 59.60%+0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Financial Results 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

8 Sep 2026 15:51 IST BSE

Annual General Meeting

Everest Organics Annual General Meeting

Everest Organics dispatched the notice for its 33rd AGM, convened for 30 September 2026 via VC/OAVM. The notice is enclosed with the FY 2025-26 Annual Report.

Read the filing ↗

14 Aug 2026 16:28 IST BSE

Management Change

Everest Organics Management Change

Everest Organics Limited has appointed Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee as Non-Executive Independent Directors. This leadership change strengthens the company's board governance.

Read the filing ↗

14 Aug 2026 16:27 IST BSE

Board Meeting Outcome

Everest Organics Board Meeting Outcome

Everest Organics Limited appointed two additional independent directors, Mr. Srikanth Reddy Kolli and Mr. Subroto Banerjee, during its board meeting. The company also scheduled its 33rd AGM.

Read the filing ↗

14 Aug 2026 16:24 IST BSE

Financial Results

Everest Organics Q1 FY27 Results: Net Profit ₹1.1 Cr, Down 21.4% YoY

Everest Organics Ltd reported revenue from operations of ₹48.4 Cr (-10.0% YoY) and net profit of ₹1.1 Cr (-21.4% YoY) for Q1 FY27.

Key figure: Net profit ₹1.1 Cr · -21.4% YoY

Open full results → Read the filing ↗